Alternative investment management firm Hamilton Lane (NASDAQ: HLNE) missed Wall Street’s revenue expectations in calendar Q3 2026 (fiscal Q2 2027), but sales rose 7.1% year on year to $204.4 million. Its non-GAAP profit of $1.98 per share was 18.2% above analysts’ consensus estimates.

Is now the time to buy HLNE? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

Hamilton Lane’s third quarter reflected a mix of steady growth and some areas of underperformance versus market expectations. While revenue growth was driven by continued expansion in specialized funds and the Evergreen Platform, management noted that sales momentum varied across segments. Co-CEO Hartley Rogers highlighted the importance of client-centricity and ongoing investments in talent and product development as key factors supporting the quarter’s performance. Executive Co-Chairman Erik Hirsch pointed to the strong net inflows in the Evergreen Platform, with nearly $800 million in new capital, and emphasized the value of diversified offerings in navigating market volatility.

Looking ahead, Hamilton Lane is focused on deepening client relationships, expanding its specialized fund lineup, and leveraging technology partnerships to drive growth. Management expects continued demand for diversified private market strategies and highlighted new partnerships, such as the integration with FactSet, as a foundation for future recurring revenue streams. Rogers stated, “Our belief is that in the private markets today, client centricity is a unique thing that we have,” while Hirsch emphasized the potential for partnerships with firms like FactSet and Columbia Threadneedle to open new avenues for growth and investor access.

Key insights from management’s remarks

Management attributed the quarter’s growth to momentum in specialized funds and product diversification, while also acknowledging the impact of evolving market sentiment and recent leadership changes.

• Specialized fund momentum: Hamilton Lane’s specialized funds, particularly the Evergreen Platform, saw significant AUM growth, with net inflows accelerating to nearly $800 million in the quarter, supported by a diverse array of product offerings.
• Leadership transition: The firm announced the planned retirement of long-time leader Mario Giannini and the appointment of Hartley Rogers as Co-CEO alongside Juan, signaling a continued focus on leadership continuity and talent development.
• Closed-end fund expansion: Several flagship strategies, including the seventh secondary fund and latest Venture fund, achieved initial closes, with management fees turning on and retroactive fees expected as subsequent closes occur, boosting near-term fee-related revenues.
• Technology partnerships: The newly announced strategic partnership with FactSet is designed to integrate Hamilton Lane’s private markets data and analytics into FactSet’s platform, establishing a recurring revenue stream and broadening access for institutional investors.
• Expense discipline and growth investments: While total expenses increased year-over-year due to headcount and technology investments, management emphasized proactive cost control in other areas and highlighted the role of balance sheet investments in seeding new products and partnerships.

Drivers of future performance

Hamilton Lane’s outlook centers on continued product expansion, deeper technology integration, and navigating a dynamic fundraising environment.

• Product lineup expansion: The company is launching new funds in GP-led secondaries, credit, and impact investing, aiming to capture broader investor demand and leverage its existing distribution and deal sourcing capabilities.
• Strategic partnerships and data: Management expects technology integrations, such as the FactSet partnership, to drive new recurring revenue and position Hamilton Lane as a key provider of private market analytics, while also supporting client decision-making in increasingly unified public-private portfolios.
• Fundraising and market risks: While fundraising momentum is supported by both existing and new clients, management cautioned that flows may remain variable due to macroeconomic uncertainty, shifting investor sentiment, and competitive pressure across the private markets industry.

Catalysts in upcoming quarters

Over the coming quarters, the StockStory team will be monitoring (1) the pace of fundraising and net inflows across both specialized and evergreen funds, (2) execution and uptake of technology partnerships like FactSet, especially in generating recurring revenue and analytics adoption, and (3) the transition in executive leadership and its impact on strategic direction. Continued product launches and the evolving competitive landscape in private markets will also be key factors shaping Hamilton Lane’s performance.

Hamilton Lane currently trades at $91.05, up from $87.84 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).

High quality stocks for all market conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today.